Company Overview
Snapshot
Founded in February 2018 by Rivka Sara Gorban and Alexey Buditskiy, Natan Labs operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing at-home diagnostic technologies.
Business overview
Natan Labs is an R&D-stage company specializing in at-home diagnostic technologies within the Health Tech & Life Sciences sector. The company's core technology involves separating whole blood into its components (red blood cells, white blood cells, and plasma) without the need for a centrifuge or skilled laboratory technician. Additionally, Natan Labs is developing at-home PCR technology that simplifies sample preparation, serving markets globally, including Europe and North America, with a focus on patients and digital healthcare.
Log in to access full profile ›Company Intelligence Q&A
- What is Natan Labs' primary focus?
- Natan Labs is primarily focused on the research and development of at-home diagnostic technologies, aiming to simplify complex medical procedures for patient use.
- What specific technologies is Natan Labs developing?
- Natan Labs is developing technology for separating whole blood into its components (red blood cells, white blood cells, and plasma) without a centrifuge, and at-home PCR technology that does not require a skilled laboratory technician.
- Who founded Natan Labs?
- Natan Labs was founded by Rivka Sara Gorban, who serves as CEO, and Alexey Buditskiy, who serves as CFO/COO.
- What markets does Natan Labs target?
- Natan Labs targets global markets, with a specific focus on Europe and North America for its diagnostic technologies.
- What is Natan Labs' current product development stage?
- Natan Labs is currently in the R&D stage, developing at-home diagnostic technologies.